Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for SARTORIUS (SSSGY : OTC)

• Company Description    Sartorius AG is a pharmaceutical and laboratory equipment supplier. The company manufactures equipment for biomolecular and microbial separations, cell culture, concentration, fermentation and purification. Sartorius AG is headquartered in Goettingen, Germany. Number of Employees: 14,042

• Price / Volume Information    Yesterday's Closing Price: $43.93 Daily Weekly Monthly 20 Day Moving Average: 0 shares Shares Outstanding: 171.19 (millions) Market Capitalization: $7,520.94 (millions) Beta: 0.92 52 Week High: $50.95 52 Week Low: $37.87 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 0.00% -0.73% 12 Week 4.35% 1.50% Year To Date -2.37% -9.79%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL OTTO-BRENNER-STRASSE 20 - GOETTINGEN,2M 37079 DEU ph: 49-55-130-80 fax: 49-55-1308-3289 ben.orzelek@sartorius.com http://www.sartorius.com

• General Corporate Information    Officers Joachim Kreuzburg - Chief Executive Officer and Chairman Florian Funck - Chief Financial Officer Rene Faber - Member of the Executive Board Alexandra Gatzemeyer - Member of the Executive Board Rainer Lehmann - Member of the Executive Board Peer Information SARTORIUS (ABMD) SARTORIUS (DMDS) SARTORIUS (CPWY.) SARTORIUS (EQUR) SARTORIUS (ECIA) SARTORIUS (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 80385Q109 SIC: 3843 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 07/28/26 Share - Related Items Shares Outstanding: 171.19 Most Recent Split Date: 1.00 (5.00:1) Beta: 0.92 Market Capitalization: $7,520.94 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.21% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.09 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 07/28/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 43.67 PEG Ratio: - Price Ratios Price/Book: 1.65 Price/Cash Flow: 8.85 Price / Sales: 1.82 EPS Growth vs. Year Ago Period: 9.37% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: 13.27% vs. Previous Quarter: -2.88% ROE 06/30/26 - - 03/31/26 - 7.53 12/31/25 - 7.56 ROA 06/30/26 - - 03/31/26 - 2.95 12/31/25 - 2.94 Current Ratio 06/30/26 - - 03/31/26 - 0.91 12/31/25 - 0.90 Quick Ratio 06/30/26 - - 03/31/26 - 0.52 12/31/25 - 0.50 Operating Margin 06/30/26 - - 03/31/26 - 8.07 12/31/25 - 8.12 Net Margin 06/30/26 - - 03/31/26 - 4.61 12/31/25 - 4.38 Pre-Tax Margin 06/30/26 - - 03/31/26 - 9.85 12/31/25 - 9.52 Book Value 06/30/26 - - 03/31/26 - 26.60 12/31/25 - 25.56 Inventory Turnover 06/30/26 - - 03/31/26 - 2.40 12/31/25 - 2.39 Debt-to-Equity 06/30/26 - - 03/31/26 - 0.86 12/31/25 - 0.87 Debt-to-Capital 06/30/26 - - 03/31/26 - 46.17 12/31/25 - 46.46

Powered by Zacks Investment Research ©